Sunitinib Malate 50mg Capsules

Get a Price/Quote

MOQ : 100 Packs

Sunitinib Malate 50mg Capsules Specification

Salt Composition
Sunitinib Malate

Indication
Renal cell carcinoma, Gastrointestinal stromal tumor (GIST), Pancreatic neuroendocrine tumors

Dosage Form
Capsule

Feature
Oral multikinase inhibitor, high oral bioavailability

Ingredients
Sunitinib Malate, Excipients

Application
Anticancer medication

Physical Color/Texture
Yellow, hard gelatin capsule

Storage Instructions
Store below 30C, protect from light and moisture

Shelf Life
24 months

Strength
50 mg per capsule

Pack Size
28 capsules per pack

Prescription Status
Prescription only

Administration Route
Oral

Packaging Type
Blister pack

ATC Code
L01XE04

Sunitinib Malate 50mg Capsules Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Sunitinib Malate 50mg Capsules

Ending Soon: Seize the opportunity to acquire Sunitinib Malate 50mg Capsules, highlighted for their unassailable efficacy in oncology care. This kingly oral multikinase inhibitor is preeminent in the fight against renal cell carcinoma, GIST, and pancreatic neuroendocrine tumors. Encapsulated in yellow, hard gelatin for optimal integrity, each blister pack contains 28 capsules (50 mg each). Available by prescription only, these capsules offer high oral bioavailability and meet rigorous quality standards. Store below 30C; protect from moisture and light. Sale subject to availability through traders and suppliers in India.

Advanced Applications and Usage Features

Beyond its primary indications, Sunitinib Malate 50mg Capsules find utility in specialized oncological regimens, offering robust performance as an oral multikinase inhibitor. Its high oral bioavailability ensures reliable absorption, maximizing therapeutic effect. The medication is administered orally, simplifying patient compliance. The hard gelatin yellow capsule form ensures stability during storage and usage. As a prescription-only medicine, hospital and clinical settings trust its preeminent quality and efficacy throughout the 24-month shelf life.

Export Markets, Sample Policy, and Shipment Details

Sunitinib Malate 50mg Capsules are exported to major healthcare markets globally, including Asia, Europe, and the Middle East. Sale price quotations are promptly provided upon inquiry, and regulated sample policies facilitate product evaluation for large buyers. Reliable FOB ports in India ensure efficient export procedures. Shipments are prepared with meticulous care, and arrival times depend on the destination and shipping terms, guaranteeing timely product delivery to international clients.

FAQ's of Sunitinib Malate 50mg Capsules:

Q: How should Sunitinib Malate 50mg Capsules be administered?

A: These capsules are designed for oral administration and should be taken exactly as prescribed by a healthcare professional, with or without food.

Q: What are the main benefits of Sunitinib Malate 50mg Capsules?

A: Sunitinib Malate delivers unassailable efficacy against renal cell carcinoma, gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors, offering high oral bioavailability and simplified patient dosing.

Q: When should Sunitinib Malate 50mg Capsules be stored and handled with care?

A: Capsules should always be stored below 30C, protected from light and moisture, and handled according to the prescribed instructions to maintain their kingly stability and effectiveness.

Q: Where are Sunitinib Malate 50mg Capsules typically supplied or exported from?

A: These capsules are supplied and traded from India, with exports facilitated through designated and reliable FOB ports to various international markets.

Q: What is the process to request a sample of Sunitinib Malate 50mg Capsules for evaluation?

A: Interested buyers can inquire about the sample policy. Upon approval, regulated samples are provided, allowing evaluation prior to placing bulk orders.